Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEATLE study of extended infusion beta-lactam antibiotics for febrile neutropenia in hematologic patients
2018-001476-37Phase 4Active
- Sponsor
- Dra. Carlota Gudiol González. Servicio de Enfermedades Infecciosas. Hospital Universitari de Bellvitge.
- Start
- Apr 2019
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of piperacillin + tazobactam, cefepime and meropenem in febrile neutropenia (FN) (2 arms), sponsored by Dra. Carlota Gudiol González. Servicio de Enfermedades Infecciosas. Hospital Universitari de Bellvitge. Started Apr 2019; status: active.
02
Drugs
piperacillin + tazobactamcefepimemeropenem
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on 2018-001476-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001476-37.